KERI LOFTUS: Open Payments
NPI 1649569518 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,163 in 52 payments from 18 companies in 2025. Trend: 2023 $1,120 · 2024 $1,104 · 2025 $1,163
Food & beverage: $1,163
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $463 |
| Insmed, Inc. | 8 | $149 |
| Merck Sharp & Dohme LLC | 3 | $87 |
| GENZYME CORPORATION | 3 | $60 |
| Grifols USA, LLC | 2 | $52 |
| Baxter Healthcare | 2 | $44 |
| Electromed, Inc. | 3 | $42 |
| JAZZ PHARMACEUTICALS INC. | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $34 |
Products named: FASENRA, BREZTRI, Arikayce, DUPIXENT, WINREVAIR, Prolastin-C Liquid, Hillrom - Vest System Model 105 Home Care, SMARTVEST.
Industry payments across NE — which companies pay providers there.
